U.S. markets closed

Outset Medical, Inc. (OM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.65-1.96 (-3.95%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close49.61
Open50.93
Bid44.50 x 1800
Ask55.55 x 800
Day's Range45.10 - 51.07
52 Week Range42.50 - 66.96
Volume453,007
Avg. Volume286,257
Market Cap2.035B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMar 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est58.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Outset Medical to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 9, 2021
      Business Wire

      Outset Medical to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 9, 2021

      Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2020 after the close of trading on Tuesday, March 9, 2021.

    • Is Outset Medical, Inc. (NASDAQ:OM) Trading At A 49% Discount?
      Simply Wall St.

      Is Outset Medical, Inc. (NASDAQ:OM) Trading At A 49% Discount?

      Today we will run through one way of estimating the intrinsic value of Outset Medical, Inc. ( NASDAQ:OM ) by taking the...

    • Outset Medical Appoints Karen Drexler to Board of Directors
      Business Wire

      Outset Medical Appoints Karen Drexler to Board of Directors

      Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, is bolstering its board of directors with the appointment of Karen Drexler. Drexler currently serves on the boards of ResMed (NYSE: RMD), a $31B data-driven sleep and respiratory market leader; VIDA Diagnostics, developer of AI-powered lung intelligence and imaging solutions; and Tivic Health, a bioelectronic medicine company. Named one of Women Inc. magazine’s most influential corporate directors in 2018, Drexler brings to Outset a deep understanding of how to utilize data analytics and machine learning to power the user experience, while supporting the patient at home and in the hospital setting.